Studies | EBMT

Top

Study type

Disease

Group

Type of transplant / Cell therapy

Text

Language

Rare Invasive Fungal Infections (IFI) post allo- and auto-HCT

Retrospective Studies

Complications: infectious

Infectious Diseases Working Party (IDWP)

Type de traitement

Investigateur principal

Simone Cesaro & Maria Pia Esposto, Aliénor Xhaard & Silvia Corcione, Malgorzata Mikulska & Claudia Bartalucci

Clinical Outcomes of MCL after auto-transplant

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

Lymphoma Working Party (LWP)

Type de traitement

Investigateur principal

Iman Abou Dalle

Impact of conditioning regimen in outcome of cutaneous T-cell lymphoma with modern advances in allogeneic stem cell transplantation

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

Lymphoma Working Party (LWP)

Type de traitement

Investigateur principal

Dr. Federico MAZZON

CART after alloHCT and alloHCT after CART in MCL

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

Lymphoma Working Party (LWP)

Type de traitement

Investigateur principal

Dr. Isabelle Krämer

Characteristics and outcomes of relapsed mantle cell lymphoma after autologous stem cell transplant in first remission in the current era

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

Lymphoma Working Party (LWP)

Type de traitement

Investigateur principal

Dr. Nour MOUKALLED, Dr. Olivier HERMINE & Dr. Ali BAZARBACHI

Autologous stem cell transplantation in cutaneous T-cell lymphomas

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

Lymphoma Working Party (LWP)

Type de traitement

Investigateur principal

Dr. Imke KARSTEN

Outcomes of allogeneic hematopoietic cell transplantation as a consolidation following CAR Tcell therapy in lymphoma patients without disease progression: an EBMT registry study

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

Lymphoma Working Party (LWP)

Type de traitement

Investigateur principal

Dr. Remy DULERY

Autologous traNsplantation in elderly patients (≥70 years) with PCNSL: an EBMT Registry Analysis of Feasibility and Outcomes (ANNA Study)

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

Lymphoma Working Party (LWP)

Type de traitement

Investigateur principal

Dr. Teresa CALIMERI & Dr. Andrés J.M. Ferreri

Management of CNS infections in patients after haematopoietic stem cell transplantation and CAR T cell therapy – a survey on behalf of the EBMT IDWP

Closed Survey/Study

Complications: infectious

Infectious Diseases Working Party (IDWP)

Type de traitement

Investigateur principal

Martin Schmidt-Hieber

Hematopoietic Stem Cell Transplantation in Aggressive Natural Killer-Cell Leukemia

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

Lymphoma Working Party (LWP)

Type de traitement

Investigateur principal

Dr. Philipp Berning & Dr. Norbert Schmitz

Greffe de cellules souches hématopoïétiques dans la leucémie agressive à cellules NK

Études rétrospectives

Lymphome non hodgkinien (LNH)

Lymphoma Working Party (LWP)

Type de traitement

Investigateur principal

Dr. Philipp Berning & Dr. Norbert Schmitz

Outcomes of autologous and allogeneic hematopoietic stem cell transplants for the treatment of nodular lymphocyte-predominant Hodgkin lymphoma

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

Lymphoma Working Party (LWP)

Type de traitement

Investigateur principal

Dr. Carmen MARTINEZ & Dr. Anna SUREDA